Intellectual Property

Companies with Section 337 investigations at the U.S. International Trade Commission know the stakes are high and having experienced counsel is critical. Goodwin’s ITC team has substantial knowledge of complex investigations under Section 337 and has a winning track record. We represent U.S. and international clients on both sides of disputes involving patents, trademarks, copyrights and trade secrets. Our team can quickly initiate investigations and swiftly respond to new investigations, protecting clients’ products and industries.

Our ITC lawyers have first-chair experience before the ITC and know exactly how to prepare matters for trial quickly and efficiently. Our practice chair is a former ITC attorney with firsthand knowledge of the Commission’s culture. Additionally, we are adept in delivering persuasive presentations under the judges’ diverse approaches to ITC trials. A win in high-stakes ITC litigation is only as good as the remedy, and Goodwin has extensive experience dealing with U.S. Customs and the Court of International Trade on enforcement matters.

Clients rely on our experienced attorneys and science advisors to help them make sound business decisions.

Lawyers in our patent opinions and counseling practice provide strategic advice to domestic and international companies. We work closely with clients to determine offensive and defensive patent strategies. Issues we routinely address include patent infringement, invalidity, unenforceability, licensing and freedom to operate.

As the Patent Trial and Appeal Board (PTAB) becomes an increasingly popular venue for resolving patent validity disputes, having experienced counsel familiar with the PTAB’s intricacies is essential. Leveraging decades of USPTO and federal court trial experience, Goodwin’s more than 75 registered patent attorneys and agents have pioneered cutting-edge and cost-effective approaches to achieve success in all three types of America Invents Act (AIA) post-grant proceedings: inter partes review (IPR), covered business method review (CBM), and post grant review (PGR).

Pharmaceutical companies need experienced counsel to protect their regulatory interests. Goodwin’s FDA Litigation practice provides counsel, representation and strategic advice that covers all aspects of our clients’ interactions with the Food and Drug Administration. Our lawyers regularly advise clients on regulatory issues, engage with the FDA and other federal and state agencies through Citizen Petitions, comments, meetings and other petitioning, and represent drug manufacturers in Administrative Procedure Act challenges. 

Goodwin has one of the most comprehensive, technology-focused trade secret and employee mobility practices in the nation. Our team is comprised of intellectual property, employment law, patent, antitrust, and privacy and cybersecurity specialists. We have advised and represented hundreds of cutting-edge companies, entrepreneurs, investors and startup founders facing these critical issues and disputes in innovation hubs around the world.